Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
SG

SGHTStock

Nasdaq Global Select Market · Healthcare · US

$10.62 last close 2026-11-19
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment SGHT's does — no target price to set, unlike a price alert.

Near limit Ratio screen, 0 of 7 decided standards passing. AAOIFI, Dow Jones Islamic, MSCI Islamic M-Series, S&P Shariah are within 3 points of their line. If they all crossed, the majority verdict would move from Not compliant to Compliant. What would change it

Sharia status
NOT COMPLIANT
Per our in-house ratio engine
0 of 7 pass our own screen — all 7 agree here
Purification 4.88% *HTR non-permissible income 5.14%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

ORB · SCALP
Entry
$10.57
Stop
$10.40
Target
$10.91
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure4 of 5 timeframes bullish · 82.6% aligned
VWAPPrice below VWAP ($10.62)
VolumeRelative volume 2.7× the 20-day average
Momentum10-day rate of change +8.2%

SGHT is currently considered not halal (non-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

433 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Price target
$12.25
+15.3% · 6 analysts
Institutional own.
54.0%
of shares
Momentum (10d)
+8.2%
rate of change
SMC grade
C · 60
82.6% aligned
4.88% *
Purification ratio (secondary provider, uncertain)
5.14%
Non-permissible income — HTR, from filings (2025-12-31)
C · 60
SMC grade — 82.6% timeframe alignment
+8.2%
Rate of change (10d)
$12.25
Price target (+15.3%) · 6 analysts
54.0%
Institutional ownership

How the status reached this point

Non-compliant since Nov 18, 2026

First seen by our daily status check on Nov 18, 2026; it read Compliant on Nov 17, 2026, so the change landed between those two checks.

$10.49 — last close we recorded while it was still Compliant, Nov 17, 2026

Held it before Nov 18, 2026?

This site’s guidance, not a fatwa: sell within a reasonable time, and when you sell, give away any gain above the last close while it was still Compliant ($10.49), plus any dividends received since. AAOIFI’s standard does not set that reference price; it is how this site suggests drawing the line. For a ruling that applies to you, ask a qualified scholar.

Dividends from while it was still compliant are purified the usual way, by the impermissible share of the company’s income.

Work out that purification →
  • Nov 18, 2026 Compliant → Non-compliant0 of 7 decided standards pass; AAOIFI debt ratio 7.2%; figures as of Sep 30, 2026
  • Nov 17, 2026 Tracking began Nothing before this date is on record.

Read once a day from our own screen, last on Nov 18, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $583.0M as of 2026-11-18. At the 2026-11-19 close it is about $587.2M (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 7.2% (7.2% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 13.2% (13.3% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail 2 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 7.22% 30.00% Pass(22.8pp buffer)
Interest-bearing investments 13.32% 30.00% Pass(16.7pp buffer)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)
Usmani Fail 0 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 40.12% 33.00% Fail(7.1pp over)
Interest-bearing investments 74.01% 33.00% Fail(41.0pp over)
Non-liquid assets 13.24% at least 20.00% Fail(6.8pp below the floor)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)
MSCI Fail 0 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 40.12% 33.33% Fail(6.8pp over)
Cash + interest-bearing securities 74.01% 33.33% Fail(40.7pp over)
Accounts receivable 86.76% 33.33% Fail(53.4pp over)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)
FTSE Fail 0 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 39.09% 33.33% Fail(5.8pp over)
Cash + interest-bearing securities 74.01% 33.33% Fail(40.7pp over)
Accounts receivable 86.76% 50.00% Fail(36.8pp over)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)
Dow Jones Islamic Market Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 15.79% 33.00% Pass(17.2pp buffer)
Cash + interest-bearing securities 29.13% 33.00% Pass(3.9pp buffer)
Accounts receivable 5.02% 33.00% Pass(28.0pp buffer)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)
S&P Shariah Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 15.74% 33.00% Pass(17.3pp buffer)
Cash + interest-bearing securities 29.04% 49.00% Pass(20.0pp buffer)
Accounts receivable 5.00% 49.00% Pass(44.0pp buffer)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)
MSCI M-Series Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 15.74% 33.33% Pass(17.6pp buffer)
Cash + interest-bearing securities 29.04% 33.33% Pass(4.3pp buffer)
Accounts receivable 34.05% 49.00% Pass(15.0pp buffer)
Non-permissible income 5.14% 5.00% Fail(0.1pp over)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Dow Jones Islamic Market (% of 24-mo avg market cap)cash and interest ratio 3.9pts
MSCI Islamic M-Series (% of 36-mo avg market cap)cash and interest ratio 4.3pts
MSCI Islamic M-Series (% of 36-mo avg market cap)receivables ratio 15.0pts
MSCI Islamic Index (% of total assets)receivables ratio 53.4pts
Usmani (% of total assets)investments ratio 41.0pts
MSCI Islamic Index (% of total assets)cash and interest ratio 40.7pts

The numbers the ratios are built from

Read from SGHT's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $77.4M 2025-12-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $41.0M 2026-09-30 DebtLongtermAndShorttermCombinedAmount
Cash and interest-bearing securitiesCash, equivalents and marketable securities $77.7M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $104.9M 2026-09-30 Assets
Market capDenominator for AAOIFI $583.0M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $269.0M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $268.9M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $4.0M 2025-12-31 InvestmentIncomeNet

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-04, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-03-04, period ended 2025-12-31. Screened 2026-11-18.

  • Total assets$104.9M
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Interest-bearing debt$41.0M
    DebtLongtermAndShorttermCombinedAmount · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Cash and interest-bearing securities$77.7M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Receivables$13.4M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Revenue$77.4M
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-03-04
  • Interest income (non-permissible)$4.0M
    InvestmentIncomeNet · period ended 2025-12-31 · 10-K filed 2026-03-04
  • Market cap$583.0M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

6 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for SGHT. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-18 Pass → Fail filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 0 pass and 7 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

Within 3 points of the line

AAOIFI, Dow Jones Islamic, MSCI Islamic M-Series, S&P Shariah are within 3 points of their line. If they all crossed, the majority verdict would move from Not compliant to Compliant.

The ratios that move with the share price

AAOIFI's debt ratio (7.2% against a 30% line) would only fail if the market cap fell by 76%, to $140.4M. At the 2026-11-19 close it would read 7.2%.

AAOIFI's investments ratio (13.3% against a 30% line) would only fail if the market cap fell by 56%, to $258.9M. At the 2026-11-19 close it would read 13.2%.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
ABTAbbott Laboratories $201.9B —
SYKStryker Corp. $125.7B —
MDTMedtronic Plc $117.8B —
BSXBoston Scientific Corp. $71.0B —
EWEdwards Lifesciences Corp $52.2B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold SGHT

2 of the 196 funds whose filed holdings we currently hold own SGHT shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns SGHT.

You may already own it

Widely held U.S. index funds. If you own one, you own SGHT through it. None of them is a Shariah fund; the last column is our look-through of each.

FundSGHT in fundFund compliant by weight
SCHB Schwab U.S. Broad Market ETF 0.00% 53%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%

Sorted by SGHT’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names SGHT once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding SGHT
InvestorFirmPositionWeightAs of
Israel Englander Millennium Management $7M 0.0% 2026-09-30
David Shaw D. E. Shaw & Co. $3M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $2M 0.0% 2026-09-30
Chuck Royce Royce & Associates $2M 0.0% 2026-09-30
Ken Griffin Citadel Advisors $1M 0.0% 2026-09-30
Steven Cohen Point72 Asset Management $1M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

11.019.127.235.343.452025-11-202026-05-222026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
9.94
S2
10.13
S1
10.31
PIVOT
10.50
R1
10.68
R2
10.87
R3
11.05

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
7.22 – 9.06
±11.36% from 8.14, made 2026-09-14 · resolves 2026-09-21
BUY
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)65.40NEUTRAL
Stochastic %K (14)68.39NEUTRAL
CCI (20)75.75NEUTRAL
Williams %R (14)-31.61NEUTRAL
MACD (12,26,9)0.05BUY
ROC (10)11.26BUY
Momentum (10)1.09BUY
EMA (10)10.49BUY
SMA (10)10.62BUY
EMA (20)10.06BUY
SMA (20)9.93BUY
EMA (30)9.73BUY
SMA (30)9.48BUY
EMA (50)9.21BUY
SMA (50)9.11BUY
EMA (100)8.25BUY
SMA (100)7.88BUY
EMA (200)7.18BUY
SMA (200)6.25BUY

About SGHT

Healthcare · Medical Devices

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

sightsciences.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-11-09

ORB
Type · SCALP
10.57
Entry
10.40
Stop
10.91
Target
LOSS
Outcome · exit 10.40 (-1.61%)

Stop 10.40 Now 10.62 Target 10.91

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BULLISH 64
⏰ 4H BULLISH 35
🕐 1H RANGING 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+8.2%
Rate of change (10d)
2.7×
Volume vs its 20-day average
0.51
MACD (no fresh cross)
$10.45
Volume POC (today)
$10.40 – $10.59
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

CLUSTER SELL   0 buys · 6 sells

Recent: Badawi Paul sold 6092819 sh @ $9.05 (2026-10-01); Badawi David sold 1975075 sh @ $9.05 (2026-10-01); Bauerlein Alison sold 639449 sh @ $8.85 (2026-10-02)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.